Tartu ülikooli teadlased tõhustasid ravimite 3D-printimise võimalusi

A recent research project emanating from the field of farmatseutilise tehnoloogia at the University of Tartu is advancing the concept of bringing drug manufacturing closer to the point of patient care. While pharmaceutical drugs are currently produced predominantly in large-scale batches, the application of 3D printing technology presents a potential paradigm shift toward highly personalized medicine. The novel research, spearheaded by young scientist Kristiine Roostari, investigates the feasibility and potential benefits of utilizing additive manufacturing techniques for drug formulation.

The core objective is to move beyond mass production models by enabling the precise, customized printing of medications. This approach suggests a future where drug dosages and compositions can be tailored to an individual patient’s specific biological needs, rather than relying on standardized, pre-mixed tablets. This development within the Tartu academic setting highlights the convergence of advanced materials science and pharmaceutical engineering.

By mastering the technical aspects of 3D printing drug matrices, researchers aim to solve critical challenges related to drug efficacy, adherence, and waste reduction associated with current manufacturing processes. The implications of this technology are substantial. Personalized drug delivery systems could improve patient compliance by designing medications with specific release profiles—for instance, drugs that release different compounds at different times in the body.

Furthermore, this localized manufacturing capability could streamline the supply chain, potentially reducing the logistical hurdles associated with transporting temperature-sensitive or specialized drugs across long distances. Overall, the work underscores the role of advanced technological integration within modern pharmaceutical practice. It positions the farmatseutilise tehnoloogia as a key driver in developing next-generation healthcare solutions, moving the industry toward a model defined by precision and individual patient requirements.

Topics: #tartu #farmatseutilise #tehnoloogia